Pfizer has agreed to pay a fine of $490.9m to settle an investigation related to off-label marketing of immunosuppressive drug Rapamune, according to the US Department of Justice.
http://www.newstatesman.com/business/business/2013/07/pfizer-pay-491m-fine-label-marketing-rapamune-us
http://www.newstatesman.com/business/business/2013/07/pfizer-pay-491m-fine-label-marketing-rapamune-us
No comments:
Post a Comment